Supplementary Figure S5 from Combined Cellular and Biochemical Profiling to Identify Predictive Drug Response Biomarkers for Kinase Inhibitors Approved for Clinical Use between 2013 and 2017

crossref(2023)

引用 0|浏览12
暂无评分
摘要

Analysis of MEK and BRAF inhibitors approved before Nov. 2013 in a 102 cell line profiling

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要